Treanda (Bendamustine) for Lymphoma | MyLymphomaTeam

Connect with others who understand.

sign up Log in
About MyLymphomaTeam
Powered By

Treanda is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma. Treanda is sometimes prescribed as part of a chemotherapy regimen in combination with other drugs such as Rituxan. Treanda is also referred to by its drug name, bendamustine.

Treanda is an anticancer drug used in chemotherapy. Treanda is a member of a class of drugs called alkylating agents. Treanda is believed to work by preventing the production of DNA in cells, blocking cell division.

How do I take it?
Treanda is administered as an intravenous infusion during chemotherapy treatment.

Side effects
The FDA-approved label for Treanda lists common side effects including nausea, fatigue, low blood cell counts, vomiting, diarrhea, fever, constipation, loss of appetite, cough, headache, weight decreased, indigestion, rash, and stomach flu.

Rare but serious side effects listed for Treanda include severe skin reactions, liver damage, increased risk for other types of cancer, hypersensitivity reactions, and fetal harm.

For more details about this treatment, visit:

Treanda — Cephalon

Lymphoma – Non-Hodgkin: Treatment Options —

Continue with Facebook
Continue with Google
Your privacy is our priority. By continuing, you accept our Terms of use and Privacy policy.
Already a Member? Log in